{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T03:58:23Z","timestamp":1788667103259,"version":"build-2803163510"},"reference-count":83,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Drug Delivery"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1080\/10717544.2021.1902023","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T14:04:48Z","timestamp":1617199488000},"page":"642-654","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":24,"title":["Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:\n            <i>in-vitro<\/i>\n            optimization and\n            <i>ex-vivo<\/i>\n            assessment"],"prefix":"10.1080","volume":"28","author":[{"given":"Eman","family":"Abdelhakeem","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El-Nabarawi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab","family":"Shamma","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40199-020-00355-8"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.3109\/10837450.2011.614251"},{"key":"e_1_3_3_4_1","first-page":"5449","article-title":"Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia","volume":"9","author":"Aburahma MH","year":"2014","unstructured":"Aburahma MH, Shamma RN, Aburahma MH. (2014). Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia. Int J Nanomedicine 9:5449\u201360.","journal-title":"Int J Nanomedicine"},{"key":"e_1_3_3_5_1","first-page":"69","article-title":"Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide\/protein-based therapeutics or vaccines","volume":"1","author":"Aburahma MH.","year":"2014","unstructured":"Aburahma MH. (2014). Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide\/protein-based therapeutics or vaccines. Drug Deliv 1\u201321; 69\u201385.","journal-title":"Drug Deliv"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2010.09.007"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/10717544.2014.923958"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1296182"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.09.017"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2010.03.034"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/nano9030474"},{"key":"e_1_3_3_12_1","first-page":"s91","article-title":"Optimization of hydrophilic matrix tablets using a D-optimal design","volume":"51","author":"Bodea A","year":"1997","unstructured":"Bodea A, Leucuta SE. (1997). Optimization of hydrophilic matrix tablets using a D-optimal design. Int J Pharm 51:s91\u2013s97.","journal-title":"Int J Pharm"},{"key":"e_1_3_3_13_1","first-page":"94","article-title":"A study of the temperature-dependent micellization of pluronic F127","volume":"477","author":"Bohorquez M","year":"1999","unstructured":"Bohorquez M, Koch C, Trygstad T, Pandit N. (1999). A study of the temperature-dependent micellization of pluronic F127. J Colloid Interface Sci 477:94\u2013102.","journal-title":"J Colloid Interface Sci"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318297a07a"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(02)00338-7"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12392"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(95)04286-5"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oftal.2017.05.002"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-018-0137-8"},{"key":"e_1_3_3_20_1","first-page":"63","article-title":"Preparation and characterization of a nanostructured lipid carrier for a poorly soluble drug","volume":"516","author":"Chen Y","year":"2014","unstructured":"Chen Y, Yang X, Zhao L, et\u00a0al. (2014). Preparation and characterization of a nanostructured lipid carrier for a poorly soluble drug. Colloids Surf A Physicochem Eng Asp 516:63\u201371.","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S86778"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.11.1448"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2007.12.015"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1021\/la5030197"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.5.2.2"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2010.02.013"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-011-9708-9"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.2174\/1872210511307010041"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0031-9384(92)90419-3"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2010.130"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.4103\/1735-5362.235156"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.02.051"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2018.10.017"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2018.03.012"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2015.04.005"},{"key":"e_1_3_3_36_1","first-page":"146","article-title":"Original research article effect of surfactant and oil type on size droplets of original research article effect of surfactant and oil type on size droplets of betacarotene-bearing nanoemulsions the use of nano carriers for hydrophobic","volume":"4","author":"Hasan F","year":"2017","unstructured":"Hasan F, Pereshki A, Hamishehkar H. (2017). Original research article effect of surfactant and oil type on size droplets of original research article effect of surfactant and oil type on size droplets of betacarotene-bearing nanoemulsions the use of nano carriers for hydrophobic. Int J Curr Microbiol Appl Sci 4:146\u201355.","journal-title":"Int J Curr Microbiol Appl Sci"},{"key":"e_1_3_3_37_1","first-page":"146","article-title":"Effect of surfactant and oil type on size droplets of betacarotene bearing nanoemulsions","volume":"4","author":"Hasani F","year":"2015","unstructured":"Hasani F, Pezeshki A, Hamishehkar H. (2015). Effect of surfactant and oil type on size droplets of betacarotene bearing nanoemulsions. Int J Curr Microbiol Appl Sci 4:146.","journal-title":"Int J Curr Microbiol Appl Sci"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0987(02)00241-5"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0142-9612(02)00578-1"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2005.08.005"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(02)00081-9"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2004.03.037"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.101489"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.3109\/10717544.2013.870260"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(00)00378-1"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639040600814676"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2016.1220570"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11010040"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.4103\/2230-973X.167661"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2013.12.023"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2012.10.031"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.2174\/157016106775203126"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.11.028"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2018.03.014"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2018.03.014"},{"key":"e_1_3_3_56_1","first-page":"1284","article-title":"Comparison of two mineralocorticoid receptor antagonists in the treatment of central serous chorioretinopathy","volume":"56","author":"Pichi F","year":"2015","unstructured":"Pichi F, Carrai P, Ciardella A, et\u00a0al. (2015). Comparison of two mineralocorticoid receptor antagonists in the treatment of central serous chorioretinopathy. Investig Ophthalmol Vis Sci 56:1284.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.14227\/DT180311P40"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.3109\/21691401.2014.909820"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2014.07.007"},{"key":"e_1_3_3_60_1","first-page":"167","article-title":"Comparison of two mineral corticosteroids receptor antagonists for the treatment of central serous chorioretinopathy","volume":"35","author":"Pichi F","year":"2017","unstructured":"Pichi F, Carrai P, Ciardella A, et\u00a0al. (2017). Comparison of two mineral corticosteroids receptor antagonists for the treatment of central serous chorioretinopathy. Int Ophthalmol 35:167\u201371.","journal-title":"Int Ophthalmol"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.4155\/fsoa-2016-0030"},{"key":"e_1_3_3_62_1","first-page":"45","article-title":"Nanostructured lipid carriers: a novel generation of solid lipid drug carriers","volume":"17","author":"Radtke M","year":"2005","unstructured":"Radtke M, Souto EB, M\u00fcller RH. (2005). Nanostructured lipid carriers: a novel generation of solid lipid drug carriers. Pharm Technol Eur 17:45\u201350.","journal-title":"Pharm Technol Eur"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1556\/AChrom.21.2009.4.8"},{"key":"e_1_3_3_64_1","first-page":"CD011841","article-title":"Interventions for central serous chorioretinopathy: a network meta-analysis","volume":"12","author":"Salehi M","year":"2015","unstructured":"Salehi M, Wenick AS, Law HA, et\u00a0al. (2015). Interventions for central serous chorioretinopathy: a network meta-analysis. Cochrane Database Syst Rev 12:CD011841.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20150422-06"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-010-9553-2"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2006.01.022"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1159\/000081633"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1080\/08982104.2017.1327541"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1080\/026520499289185"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcis.2014.04.057"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(02)00639-7"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.03.034"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-00477-3_4"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.4314\/tjpr.v13i5.1"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2012.11.005"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S64103"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-014-0078-y"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(93)90177-H"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1080\/08820538.2016.1228418"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2018.03.117"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1039\/C6RA27096D"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI61427"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.09-154344"}],"container-title":["Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10717544.2021.1902023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T15:57:27Z","timestamp":1724169447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10717544.2021.1902023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1080\/10717544.2021.1902023"],"URL":"https:\/\/doi.org\/10.1080\/10717544.2021.1902023","relation":{},"ISSN":["1071-7544","1521-0464"],"issn-type":[{"value":"1071-7544","type":"print"},{"value":"1521-0464","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idrd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idrd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-02-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}